2016 Form 10-K Financial Statement
#000114420417007088 Filed on February 09, 2017
Income Statement
Concept | 2016 | 2015 Q4 | 2015 |
---|---|---|---|
Revenue | $12.03M | $2.740M | $7.300M |
YoY Change | 64.76% | 94.33% | 32.42% |
Cost Of Revenue | $7.113M | $1.600M | $3.951M |
YoY Change | 80.04% | 142.42% | 53.81% |
Gross Profit | $4.915M | $1.140M | $3.349M |
YoY Change | 46.74% | 52.0% | 13.75% |
Gross Profit Margin | 40.86% | 41.61% | 45.88% |
Selling, General & Admin | $15.73M | $3.390M | $12.73M |
YoY Change | 23.55% | 44.26% | 66.67% |
% of Gross Profit | 320.03% | 297.37% | 380.12% |
Research & Development | $4.394M | $1.070M | $3.895M |
YoY Change | 12.83% | 33.75% | -4.45% |
% of Gross Profit | 89.42% | 93.86% | 116.29% |
Depreciation & Amortization | $251.3K | $60.00K | $222.6K |
YoY Change | 12.91% | 20.0% | 53.41% |
% of Gross Profit | 5.11% | 5.26% | 6.65% |
Operating Expenses | $20.12M | $4.460M | $16.63M |
YoY Change | 21.04% | 41.14% | 41.92% |
Operating Profit | -$15.21M | -$3.320M | -$13.28M |
YoY Change | 14.55% | 37.76% | 51.38% |
Interest Expense | $290.0K | $610.0K | $4.090M |
YoY Change | -92.91% | -222.0% | 289.52% |
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Pretax Income | -$14.91M | -$2.710M | -$9.190M |
YoY Change | 62.24% | -6.87% | 18.28% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$14.91M | -$2.710M | -$9.187M |
YoY Change | 62.32% | -6.87% | 18.3% |
Net Earnings / Revenue | -123.99% | -98.91% | -125.86% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$248.5M | -$67.75M | -$306.3M |
COMMON SHARES | |||
Basic Shares Outstanding | |||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2016 | 2015 Q4 | 2015 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $3.950M | $12.46M | $12.46M |
YoY Change | -68.3% | 35.14% | 35.14% |
Cash & Equivalents | $3.950M | $12.46M | $12.46M |
Short-Term Investments | |||
Other Short-Term Assets | $1.650M | $850.0K | $850.0K |
YoY Change | 94.12% | 39.34% | 39.34% |
Inventory | $1.250M | $1.089M | $1.090M |
Prepaid Expenses | |||
Receivables | $740.0K | $742.7K | $810.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $7.590M | $15.15M | $15.21M |
YoY Change | -50.1% | 36.58% | 37.15% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $530.0K | $683.5K | $680.0K |
YoY Change | -22.06% | 119.42% | 119.35% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $160.0K | $200.0K | $200.0K |
YoY Change | -20.0% | ||
Total Long-Term Assets | $690.0K | $887.2K | $890.0K |
YoY Change | -22.47% | 184.27% | 187.1% |
TOTAL ASSETS | |||
Total Short-Term Assets | $7.590M | $15.15M | $15.21M |
Total Long-Term Assets | $690.0K | $887.2K | $890.0K |
Total Assets | $8.280M | $16.03M | $16.10M |
YoY Change | -48.57% | 40.63% | 41.23% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $730.0K | $1.060M | $1.060M |
YoY Change | -31.13% | 102.75% | 103.85% |
Accrued Expenses | $1.960M | $1.055M | $1.900M |
YoY Change | 3.16% | -16.55% | -11.63% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $3.320M | $3.257M | $3.260M |
YoY Change | 1.84% | 20.7% | 20.74% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $280.0K | $280.0K |
YoY Change | -100.0% | -94.74% | -94.74% |
Total Long-Term Liabilities | $0.00 | $280.0K | $280.0K |
YoY Change | -100.0% | -94.74% | -94.74% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.320M | $3.257M | $3.260M |
Total Long-Term Liabilities | $0.00 | $280.0K | $280.0K |
Total Liabilities | $3.320M | $3.537M | $3.540M |
YoY Change | -6.21% | -55.87% | -55.86% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$163.6M | ||
YoY Change | 5.95% | ||
Common Stock | $405.00 | ||
YoY Change | 98.53% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $4.960M | $12.56M | $12.56M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $8.280M | $16.10M | $16.10M |
YoY Change | -48.57% | 41.2% | 41.23% |
Cashflow Statement
Concept | 2016 | 2015 Q4 | 2015 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$14.91M | -$2.710M | -$9.187M |
YoY Change | 62.32% | -6.87% | 18.3% |
Depreciation, Depletion And Amortization | $251.3K | $60.00K | $222.6K |
YoY Change | 12.91% | 20.0% | 53.41% |
Cash From Operating Activities | -$15.08M | -$3.480M | -$13.10M |
YoY Change | 15.11% | 49.36% | 70.57% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $100.5K | $0.00 | $594.6K |
YoY Change | -83.1% | -100.0% | 161.59% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$100.0K | $0.00 | -$590.0K |
YoY Change | -83.05% | -100.0% | 156.52% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 6.670M | 6.830M | 16.94M |
YoY Change | -60.63% | 68200.0% | 113.62% |
NET CHANGE | |||
Cash From Operating Activities | -15.08M | -3.480M | -13.10M |
Cash From Investing Activities | -100.0K | 0.000 | -590.0K |
Cash From Financing Activities | 6.670M | 6.830M | 16.94M |
Net Change In Cash | -8.510M | 3.350M | 3.250M |
YoY Change | -361.85% | -235.08% | 16150.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$15.08M | -$3.480M | -$13.10M |
Capital Expenditures | $100.5K | $0.00 | $594.6K |
Free Cash Flow | -$15.18M | -$3.480M | -$13.69M |
YoY Change | 10.85% | 60.37% | 73.19% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-13099853 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-15080276 | USD |
CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
594606 | USD |
CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
100499 | USD |
CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-594606 | USD |
CY2016 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-275662 | USD |
CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9187348 | USD |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-14913151 | USD |
CY2015Q4 | nuro |
Common Stock Warrants
CommonStockWarrants
|
280303 | USD |
CY2015Q4 | us-gaap |
Liabilities
Liabilities
|
3536893 | USD |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
669 | USD |
CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
405 | USD |
CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-163565650 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4960764 | USD |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12562708 | USD |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8283891 | USD |
CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
16099601 | USD |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3318486 | USD |
CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3256590 | USD |
CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2016Q4 | nuro |
Common Stock Warrants
CommonStockWarrants
|
4641 | USD |
CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
3323127 | USD |
CY2016Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
183438878 | USD |
CY2015Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
176127932 | USD |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-178478801 | USD |
CY2014 | us-gaap |
Revenues
Revenues
|
5512764 | USD |
CY2015 | us-gaap |
Revenues
Revenues
|
7299830 | USD |
CY2016 | us-gaap |
Revenues
Revenues
|
12027528 | USD |
CY2015 | us-gaap |
Gross Profit
GrossProfit
|
3349084 | USD |
CY2014 | us-gaap |
Gross Profit
GrossProfit
|
2944162 | USD |
CY2014 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2568602 | USD |
CY2015 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
3950746 | USD |
CY2016 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
7113005 | USD |
CY2016 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-267583 | USD |
CY2015 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
57349 | USD |
CY2016 | us-gaap |
Gross Profit
GrossProfit
|
4914523 | USD |
CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4075976 | USD |
CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3894786 | USD |
CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4394353 | USD |
CY2014 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2913112 | USD |
CY2015 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
7232971 | USD |
CY2016 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
10855445 | USD |
CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4725123 | USD |
CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5497513 | USD |
CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4872670 | USD |
CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
11714211 | USD |
CY2015 | us-gaap |
Operating Expenses
OperatingExpenses
|
16625270 | USD |
CY2016 | us-gaap |
Operating Expenses
OperatingExpenses
|
20122468 | USD |
CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8770049 | USD |
CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13276186 | USD |
CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-15207945 | USD |
CY2014 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
4606 | USD |
CY2015 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
5232 | USD |
CY2016 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
19132 | USD |
CY2014 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1050095 | USD |
CY2015 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-4083606 | USD |
CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7766222 | USD |
CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-6.15 | |
CY2015 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-7.75 | |
CY2016 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-7.28 | |
CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1743494 | shares |
CY2015 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2719285 | shares |
CY2016 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4777037 | shares |
CY2016 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
0 | USD |
CY2015 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
0 | USD |
CY2014 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
50874 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
289873 | USD |
CY2016 | nuro |
Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
|
6738500 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
CY2014 | nuro |
Stock Issued During Period Value To Settle Incentive Compensation Obligations
StockIssuedDuringPeriodValueToSettleIncentiveCompensationObligations
|
104405 | USD |
CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
302415 | USD |
CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
225408 | USD |
CY2014 | nuro |
Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
|
3539947 | USD |
CY2015 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
CY2016 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
CY2015 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
37824 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
24137 | USD |
CY2015 | nuro |
Stock Issued During Period Value To Settle Incentive Compensation Obligations
StockIssuedDuringPeriodValueToSettleIncentiveCompensationObligations
|
281757 | USD |
CY2016 | nuro |
Stock Issued During Period Value To Settle Incentive Compensation Obligations
StockIssuedDuringPeriodValueToSettleIncentiveCompensationObligations
|
318761 | USD |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3387115 | USD |
CY2015 | nuro |
Issuance Of Preferred Stock And Warrants Under Underwritten Public Offerieng Value
IssuanceOfPreferredStockAndWarrantsUnderUnderwrittenPublicOfferiengValue
|
13290379 | USD |
CY2015 | nuro |
Stock Issued During Period Value Redemption Of Preferred Stock
StockIssuedDuringPeriodValueRedemptionOfPreferredStock
|
2262934 | USD |
CY2015 | nuro |
Stock Issued During Period Values Preferred Stock And Warrants
StockIssuedDuringPeriodValuesPreferredStockAndWarrants
|
6713500 | USD |
CY2015 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
222592 | USD |
CY2016 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
251327 | USD |
CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
302415 | USD |
CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
225408 | USD |
CY2015 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
225619 | USD |
CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-69096 | USD |
CY2015 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
409344 | USD |
CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
163154 | USD |
CY2015 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
447541 | USD |
CY2016 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
347176 | USD |
CY2015 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
192489 | USD |
CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
754797 | USD |
CY2015 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
478760 | USD |
CY2016 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
401064 | USD |
CY2015 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
-281757 | USD |
CY2016 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
-318761 | USD |
CY2016 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
0 | USD |
CY2015 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
0 | USD |
CY2016 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
6667038 | USD |
CY2015 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
20141703 | USD |
CY2014 | us-gaap |
Depreciation
Depreciation
|
145100 | USD |
CY2016Q4 | nuro |
Technology Fees
TechnologyFees
|
450000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-100499 | USD |
CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
3240887 | USD |
CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-8513737 | USD |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9221985 | USD |
CY2016 | us-gaap |
Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
|
0 | USD |
CY2015 | us-gaap |
Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
|
3206357 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
6667038 | USD |
CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
16935346 | USD |
CY2016 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
0 | USD |
CY2015 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
0 | USD |
CY2014 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
145100 | USD |
CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
289873 | USD |
CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
189318 | USD |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
5.02 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
14.72 | |
CY2016Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.85 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.95 | |
CY2015Q4 | nuro |
Technology Fees
TechnologyFees
|
450000 | USD |
CY2016Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
382000 | USD |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.24 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.67 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
4857.94 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.57 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y1M6D | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y10M24D | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y | |
CY2016Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
487922 | USD |
CY2016Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
782364 | shares |
CY2016Q4 | nuro |
Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Price Per Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAveragePricePerShares
|
4.57 | |
CY2016 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y2M12D | |
CY2016 | us-gaap |
Depreciation
Depreciation
|
251327 | USD |
CY2015 | us-gaap |
Depreciation
Depreciation
|
222592 | USD |
CY2015Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
336229 | USD |
CY2016Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
48140 | USD |
CY2015Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
56284 | USD |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.07 | pure |
CY2016Q4 | nuro |
Accrued Consulting Fees
AccruedConsultingFees
|
48000 | USD |
CY2015Q4 | nuro |
Accrued Consulting Fees
AccruedConsultingFees
|
92000 | USD |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.042 | pure |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.085 | pure |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
232391 | USD |
CY2015Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
120970 | USD |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.002 | pure |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.145 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.036 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.009 | pure |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.013 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
|
-0.01 | pure |
CY2014 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
116704 | USD |
CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
195454 | USD |
CY2014 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
199975 | USD |
CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
998434 | USD |
CY2014 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-44956 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-227308 | USD |
CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
26232 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9195753 | USD |
CY2014 | nuro |
Stock Issuance Settle Incentive Compensation Obligation
StockIssuanceSettleIncentiveCompensationObligation
|
-104405 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7932033 | USD |
CY2014 | us-gaap |
Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
|
0 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7932033 | USD |
CY2014 | nuro |
Supplemental Warrant Issued To Placement Agent And Investors In Private Placement
SupplementalWarrantIssuedToPlacementAgentAndInvestorsInPrivatePlacement
|
4418824 | USD |
CY2014 | nuro |
Equity Offering Costs Included In Accounts Payable And Accrued Expenses
EquityOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
0 | USD |
CY2016 | nuro |
Equity Offering Costs Included In Accounts Payable And Accrued Expenses
EquityOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
0 | USD |
CY2015 | nuro |
Equity Offering Costs Included In Accounts Payable And Accrued Expenses
EquityOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
100000 | USD |
CY2016 | us-gaap |
Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
|
6700000 | USD |
CY2016 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
7500000 | USD |
CY2016Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
45879 | USD |
CY2015Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
10484 | USD |
CY2016 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.12 | pure |
CY2015 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.19 | pure |
CY2014 | nuro |
Sales Revenue Goods Net Percentage From Foreign Country
SalesRevenueGoodsNetPercentageFromForeignCountry
|
0.19 | pure |
CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
31815153 | shares |
CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5694372 | shares |
CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
963556 | shares |
CY2016 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
0 | USD |
CY2015 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
4140446 | USD |
CY2014 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Embedded Features
DeemedDividendsAttributableToPreferredStockInConnectionWithEmbeddedFeatures
|
2955668 | USD |
CY2016 | nuro |
Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features
ReturnOfCapitalToCommonShareholdersAttributableFromRepurchaseOfPreferredSharesAndRelatedEmbeddedBeneficialConversionFeatures
|
0 | USD |
CY2015 | nuro |
Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features
ReturnOfCapitalToCommonShareholdersAttributableFromRepurchaseOfPreferredSharesAndRelatedEmbeddedBeneficialConversionFeatures
|
589751 | USD |
CY2014 | nuro |
Return Of Capital To Common Shareholders Attributable From Repurchase Of Preferred Shares And Related Embedded Beneficial Conversion Features
ReturnOfCapitalToCommonShareholdersAttributableFromRepurchaseOfPreferredSharesAndRelatedEmbeddedBeneficialConversionFeatures
|
0 | USD |
CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-21070255 | USD |
CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-10721890 | USD |
CY2016 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Preferred Stock Modification
DeemedDividendsAttributableToPreferredStockInConnectionWithPreferredStockModification
|
19846377 | USD |
CY2015 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Preferred Stock Modification
DeemedDividendsAttributableToPreferredStockInConnectionWithPreferredStockModification
|
8332212 | USD |
CY2014 | nuro |
Deemed Dividends Attributable To Preferred Stock In Connection With Preferred Stock Modification
DeemedDividendsAttributableToPreferredStockInConnectionWithPreferredStockModification
|
0 | USD |
CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
500000 | shares |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
214813 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
575500 | shares |
CY2016 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
7688 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
261 | shares |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
782364 | shares |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
679013 | shares |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
18.81 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
168229 | shares |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.48 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2016 | dei |
Entity Registrant Name
EntityRegistrantName
|
NeuroMetrix, Inc. | |
CY2016 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001289850 | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Other
EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
|
0.109 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.393 | pure |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.583 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.347 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2015 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
45759780 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
40397318 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
2180700 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
2005741 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
752866 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
704957 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
566487 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
538321 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
14321 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
13698 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
49274154 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
43660035 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
49274154 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
43660035 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2016Q4 | nuro |
Income Tax Expense Benefit Attributable To Net Operating Loss Carry Forward
IncomeTaxExpenseBenefitAttributableToNetOperatingLossCarryForward
|
3900000 | USD |
CY2016Q4 | nuro |
Income Tax Expense Benefit Attributable To Tax Credit Carry Forwards
IncomeTaxExpenseBenefitAttributableToTaxCreditCarryForwards
|
71000 | USD |
CY2016 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
581928 | USD |
CY2015 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
679026 | USD |
CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
638679 | USD |
CY2016Q4 | us-gaap |
Purchase Obligation
PurchaseObligation
|
1699823 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
833831 | USD |
CY2016Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
833831 | USD |
CY2016Q4 | nuro |
Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
|
4641 | USD |
CY2016Q4 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
4641 | USD |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
1865498 | USD |
CY2015Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
1865498 | USD |
CY2015Q4 | nuro |
Common Stock Warrants Fair Value Disclosure
CommonStockWarrantsFairValueDisclosure
|
280303 | USD |
CY2015Q4 | us-gaap |
Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
|
280303 | USD |
CY2016Q4 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
2500000 | USD |
CY2016 | us-gaap |
Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
|
2018-01-15 | |
CY2016Q4 | nuro |
Restricted Cash Collateral Letters Of Credit
RestrictedCashCollateralLettersOfCredit
|
896571 | USD |
CY2016Q4 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
1600000 | USD |
CY2016Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
29154716 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6694901 | shares |
CY2016 | nuro |
Minimum Closing Bid Price In Market
MinimumClosingBidPriceInMarket
|
1.00 | |
CY2016 | nuro |
Minimum Bid Closing Price Of Ten Consecutive Business Days Per Shares
MinimumBidClosingPriceOfTenConsecutiveBusinessDaysPerShares
|
1.00 | |
CY2016 | nuro |
Common Stock Outstanding Immediately Prior To Reverse Stock Split
CommonStockOutstandingImmediatelyPriorToReverseStockSplit
|
13785239 | shares |
CY2016 | us-gaap |
Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
|
3446274 | shares |
CY2016 | dei |
Document Type
DocumentType
|
10-K | |
CY2016 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2016 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2016-12-31 | |
CY2016 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2016 | |
CY2016 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2016 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2016 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2016 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2016 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2016 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
CY2016Q2 | dei |
Entity Public Float
EntityPublicFloat
|
7760679 | USD |
CY2016 | dei |
Trading Symbol
TradingSymbol
|
NURO | |
CY2017Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7914901 | shares |
CY2016Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
628236 | USD |
CY2015Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
227172 | USD |
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2015Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
25000 | USD |
CY2015Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
25000 | USD |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2016 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
19846377 | USD |
CY2015 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
11882907 | USD |
CY2014 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
2955668 | USD |
CY2016 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-34759528 | USD |
CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-21070255 | USD |
CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-10721890 | USD |
CY2015Q4 | nuro |
Stockholders Equity Note Reverse Stock Split Conversion Ratio
StockholdersEquityNoteReverseStockSplitConversionRatio
|
1-for-4 | |
CY2016 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <h2 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: bold 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> </h2> <h3 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 24px; PADDING-RIGHT: 0pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> Use of Estimates and Assumptions</h3> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances and regularly assesses these estimates, but actual results could differ materially from these estimates. Effects of changes in estimates are recorded in the period in which they occur.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2016 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left"></div> <h3 style="TEXT-ALIGN: left; PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 0pt; MARGIN: 0pt; PADDING-LEFT: 24px; PADDING-RIGHT: 0pt; FONT: bold italic 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 5pt"> Concentrations of Credit Risk</h3> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents in bank deposit accounts and trade receivables. The Company invests its funds in highly rated institutions and limits its investment in any individual account so that they do not exceed FDIC limits. The Company has not experienced significant losses related to cash and cash equivalents and does not believe it is exposed to any significant credit risks relating to its cash and cash equivalents.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">At December 31, 2016 and 2015, two customers accounted for 41% of accounts receivable and a different customer accounted for 46% of accounts receivable, respectively. For the year ended December 31, 2016 no customer accounted for more than 10% of revenue. For the years ended December 31, 2015 and 2014, one customer accounted for 12% and 30% of revenue.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;PADDING-BOTTOM: 3pt; TEXT-TRANSFORM: none; TEXT-INDENT: 20px; MARGIN: 0pt; PADDING-LEFT: 4px; PADDING-RIGHT: 0pt; FONT: 10pt/12pt Times New Roman, Times, Serif; PADDING-TOP: 3pt" align="left">The Company relies on in-house assembly and three third-party manufacturers to manufacture the major portion of its current products and product components. The disruption or termination of the supply of these products or a significant increase in the cost of these products from these sources could have an adverse effect on the Company’s business, financial position, and results of operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6694901 | shares |
CY2016Q4 | us-gaap |
Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
|
1247545 | USD |
CY2016Q4 | us-gaap |
Other Deferred Credits Current
OtherDeferredCreditsCurrent
|
619309 | USD |
CY2015Q4 | us-gaap |
Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
|
489467 | USD |
CY2015Q4 | us-gaap |
Other Deferred Credits Current
OtherDeferredCreditsCurrent
|
262295 | USD |
CY2016Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
910595 | USD |
CY2015Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
378440 | USD |
CY2016Q4 | nuro |
Accrued Sales Return Allowance Current
AccruedSalesReturnAllowanceCurrent
|
488200 | USD |
CY2015Q4 | nuro |
Accrued Sales Return Allowance Current
AccruedSalesReturnAllowanceCurrent
|
65111 | USD |
CY2016 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
6311000 | USD |
CY2015 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
2499000 | USD |
CY2014 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
481000 | USD |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.70 | pure |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.70 | pure |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.70 | pure |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
530674 | USD |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
|
0 | |
CY2016Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
630361 | USD |
CY2015Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
656647 | USD |
CY2016Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
466906 | USD |
CY2015Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
432437 | USD |
CY2016Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
154971 | USD |
CY2015Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
0 | USD |
CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3100216 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2999717 | USD |
CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2567510 | USD |
CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2316183 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
542645 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
547018 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
475408 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
487379 | USD |
CY2016Q4 | nuro |
Operating Leases Future Minimum Payments Due In Six Years
OperatingLeasesFutureMinimumPaymentsDueInSixYears
|
81562 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
2664686 | USD |
CY2016 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
28538 | USD |
CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4047332 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4047332 | shares |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7194975 | USD |
CY2016Q4 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
2270000 | shares |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.340 | pure |
CY2016Q4 | nuro |
Minimum Bid Price Per Share
MinimumBidPricePerShare
|
1.00 |